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Abstract
We present the cases of three children with patent ductus arteriosus (PDA), pulmonary arterial
hypertension (PAH), and desaturation. One of them had desaturation associated with atrial
septal defect (ASD). His ASD, PAH, and desaturation improved after successful device closure
of the PDA. The other two had desaturation associated with Down syndrome. One had
desaturation only at room air oxygen (21% oxygen) but well saturated with 100% oxygen,
subsequently underwent successful device closure of the PDA. The other had experienced
desaturation at a younger age but spontaneously recovered when he was older, following
attempted device closure of the PDA, with late embolization of the device. (Cardiol J 2012; 19,
5: 543–546)
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Introduction
Patent ductus arteriosus (PDA) is a common
congenital heart disease. Increased pulmonary pres-
sure causing pulmonary arterial hypertension
(PAH) associated with PDA is secondary to either
increased pulmonary blood flow (PBF) or increased
pulmonary vascular resistance (PVR) [1]. If PAH
is solely caused by increased PBF, PAH will be
completely resolved after PDA closure. If PAH is
associated with high PVR, it may remain after PDA
closure. PAH is defined as mean pulmonary artery
pressure (PAP) > 25 mm Hg at rest [2]. We report
one case of PDA associated with PAH, atrial septal
defect (ASD), and desaturation, and two cases of




A two year-old boy presented with a history of
cyanosis when crying and dyspnea on exertion, with
poor weight gain since the age of seven months.
Physical examination revealed: weight 10 kg
(3rd–10th percentile), height 78 cm (< 3rd percentile),
oxygen saturation (SaO2) 91%, loud P2, and grade
3/6 systolic ejection murmur (SEM) at the left up-
per sternal border (LUSB). Chest film, electrocar-
diogram (ECG), and echocardiography findings are
summarized in Table 1. In addition, he also had
ASD, secundum type, 8 mm in diameter with bi-
directional shunting. Cardiac catheterization was
performed (Table 2). We decided to close the PDA
using an 8/6 Amplatzer ductal occluder (ADO)
(AGA™Medical Corporation) using a previously de-
scribed technique [3, 4]. At three-month follow-up,
we found clinical improvement and his echocardio-
graphy demonstrated closure of the ASD, no resi-
dual PDA, mild tricuspid regurgitation (TR), and es-
timated systolic PAP equal to 40 mm Hg. His SaO2
had returned to 97% (Fig. 1).
Case 2
A nine year-old boy with Down syndrome pre-
sented with a history of dyspnea on exertion and
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recurrent pneumonia. He had been diagnosed with
a large PDA at the age of three years, but it was
decided not to operate due to his Down syndrome.
He was still on furosemide and digitalis. Physical
examination revealed weight 15.4 kg (< 3rd percen-
tile), height 103 cm (< 3rd percentile), SaO2 100%
(right hand) and 90% (right foot), loud P2, and grade
3/6 SEM at LUSB. Chest film, ECG, and echocar-
diography findings are summarized in Table 1. Car-
diac catheterization was performed (Table 2).
At room air oxygen (21% oxygen), he had desatu-
ration (femoral artery SaO2 91%). However, giving
100% O2 eliminated his desaturation. We decided
to close the PDA using a 12/10 ADO. At three-
month follow-up, we found clinical improvement and
his echocardiography demonstrated no residual
PDA, mild TR, and estimated systolic PAP equal
to 40 mm Hg (Fig. 2).
Case 3
A 13 year-old boy with Down syndrome pre-
sented with a known case of PDA. At the age of nine
months, he was found to have desaturation (SaO2
70%) and underwent cardiac catheterization (Table 2).
He was conservatively followed due to the belief
that the PDA was  inoperable. He remained asymp-
tomatic with improved SaO2 to 95%. At the age of
nine years, he underwent another cardiac cathete-
rization (Table 2). Surgical closure of the PDA was
discussed, but his parents decided against the sur-
gery. He was then followed until he was 13 years
old. Physical examination revealed: weight 25.4 kg
(< 3rd percentile), height 131 cm (< 3rd percentile),
SaO2 97%, loud P2, and grade 2/6 SEM at LUSB.
Chest film, ECG, and echocardiography findings are
summarized in Table 1. Cardiac catheterization was
performed (Table 2). After discussion with his pa-
Table 1. Summary of chest film, electrocardiography, and echocardiography in each patient.
Investigations Patient 1 Patient 2 Patient 3
Chest film CTR 0.56; ≠PBF CTR 0.55; ≠PBF CTR 0.62; ≠PBF
Electrocardiography RAD; QRS axis +150°; Normal axis; QRS axis +60°; RAD; QRS axis +105°;
RVH LVH LVH, RVH
Echocardiography:
PDA size [mm] 5–6 7–8 12
LA/Ao ratio 1.5 1.1 1.2
TR severity Mild Mild Mild to moderate
TR PG [mm Hg] 45 50 86
Ao — aorta; CTR — cardio-thoracic ratio; LA — left atrium; LVH — left ventricular hypertrophy; PBF — pulmonary blood flow; PG — pressure
gradient; RAD — right axis deviation; RVH — right ventricular hypertrophy; TR — tricuspid regurgitation
Table 2. Summary of cardiac catheterization data in each patient.
Parameters Patient 1 Patient 2 Patient 3
21% O2 21% O2 100% O2 21% O2
Age: 2 y 9 y 9 y 9 mo 9 y 13 y
SVC sat (%) 69 72 91 52 52 51
FA sat (%) 91 89* 100† 65 96 98
PA sat (%) 86 80 99‡ 56 86 88
PAP [mm Hg] 57/32 (43) 70/39 (55) 57/25 (40) 69/46 (53) 71/38 (52) 82/39 (58)
QP/QS 1.8 1.1 7.0 0.28 2.7 4.7
PVR [Wood units] 4.2 6.1 0.9 25.5 5.7 4.2
AoP [mm Hg] 73/40 (54) 104/53 (70) 107/48 (71) 74/46 (57) 113/49 (70) 100/69 (85)
Mean PAP/AoP (%) 80 79 56 93 74 68
PDA diameter Ao/PA ends [mm] 6.3/4.2                    8.0/6.2 5/5 12/12 12/12
Size of ADO 8/6                      12/10 – – 16/14
*At room air oxygen (21%) and after sedation. His PCO2 was increased to 55 mm Hg with pH 7.3. His oxygen saturation in the ascending aorta was 96%
compared to 89% in the femoral artery (differential cyanosis); †PaO2 404 mm Hg; ‡PaO2 210 mm Hg; ADO — Amplatzer ductal occluder; Ao — aorta;
AoP — aortic pressure; FA — femoral artery; O2 — oxygen; QP/QS — pulmonary blood flow/systemic blood flow; PA — pulmonary artery;
PAP — pulmonary arterial pressure; PDA — patent ductus arteriosus; PVR — pulmonary vascular resistance; SVC — superior vena cava
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rents, we decided to close the PDA using a 16/14
ADO. The systolic PAP after PDA device was de-
creased to 50 mm Hg. Echocardiography on day one
after the procedure revealed the ADO device was
in the proper position with a residual PDA, 3 mm
in diameter, mild to moderate TR, and estimated
systolic PAP equal to 55 mm Hg. However, at three-
-month follow-up, his echocardiography demonstrat-
ed large PDA with embolization of the ADO device
into the descending aorta, mild to moderate TR, and
estimated systolic PAP increased to 105 mm Hg.
Cardiac catheterization was performed with at-
tempted ADO device removal using a percutane-
ous snare. However, it was unsuccessful due to the
difficulty of dislodging the ADO device from the
abdominal aorta. The ADO device was then suc-
cessfully removed surgically. We discussed with his
parents the option of surgery but they have not yet
decided (Fig. 3).
Discussion
A large PDA results in increased PBF and sec-
ondary PAH [5]. This leads to high PVR over time,
but is unusual in children under two years. Case 1
had PDA with moderate left to right shunt (calculated
pulmonary to systemic blood flow, QP:QS = 1.8),
severe PAH (80% of systemic pressure), and high
PVR (4.2 Wood units). His desaturation could be
explained by a bi-directional shunt across the ASD
due to pulmonary vascular disease. As a result of
two levels of left to right shunt including ASD and
PDA, this might promote high PVR. This might be
explained in this case by his early age [6]. Never-
theless, after successful PDA device closure, his
ASD was smaller and eventually closed. This led
to resolution of his desaturation and partial improve-
ment in his PAH.
 Children with congenital heart defects and
Down syndrome have particularly high PVR and
a propensity towards early development of severe
damage to the pulmonary vascular bed characte-
rized by early progression of elevation of PVR pro-
bably due to insufficient thickness of the wall of the
pulmonary artery [7]. In this report, cases 2 and
Figure 1. Angiography in the descending aorta (DAo) in
patient 1 demonstrated contrast filled into pulmonary
artery (PA) and size of patent ductus arteriosus (PDA)
(A), and angiography after the Amplatzer ductal occlu-
der (ADO) demonstrated proper position of ADO in the
PDA (B). Figure 2. Angiography in the descending aorta (DAo) in
patient 2 demonstrated contrast filled into pulmonary
artery (PA) and size of patent ductus arteriosus (PDA)
(A), and angiography after the Amplatzer ductal occlu-
der (ADO) demonstrated proper position of ADO in the
PDA (B).
546
Cardiology Journal 2012, Vol. 19, No. 5
www.cardiologyjournal.org
3 were Down syndrome. Case 2 had high PVR at
room air oxygen (21% oxygen) with only trivial left
to right shunt. His desaturation at room air oxygen
(21% oxygen) was caused by high PVR resulting in
right to left shunt across PDA and differential cy-
anosis. However, when 100% oxygen was supplied,
his left to right shunt was increased from 1.1 to 7,
his mean PAP decreased from 55 to 40 mm Hg, and
his PVR decreased from 6.1 to 0.9 Wood units. This
indicated pulmonary vasoreactivity of his PAH by
oxygen [8]. Surgical closure of a PDA in older chil-
dren associated with PAH is often challenging due
to its thin and fragile wall, making conventional PDA
ligation and/or division extremely high risk [9].
After successful PDA device closure, his desatura-
tion was resolved and PAH was partially improved.
Case 3 had severe desaturation (SaO2 70%) with
very high PVR (25.5 Wood units) when he was only
nine months old and it was concluded that he was in-
operable at that time. This might be due to the delay
in regression of PVR in Down syndrome. Surprising-
ly, his desaturation was improved and his SaO2 re-
turned to 95%. He underwent cardiac catheterization
at the age of nine years which demonstrated large left
to right shunt, but high PVR (5.7 Wood units), al-
though his PVR was markedly decreased compared
to the previous PVR when he was nine months old.
The decision to close PDA in case 3 was delayed due
to the high risk of the procedure. The option of sur-
gery was to perform PDA closure under cardiopulmo-
nary bypass when the risk of the surgery would be
increased. Eventually, when he was 13 years old, we
decided to use the ADO device to close a PDA in this
case, since it was more advantageous to differentiate
the reversibility of PAH and high PVR along with the
use of oxygen and/or other medicine as pulmonary
vasodilator tests. Moreover, the temporary occlusion
of the PDA before it was completely deployed from
its detachable cable wire was more reliable to assess
the consequences of PDA closure and, thereby, to
evaluate the reversibility of PAH and high PVR. Due
to high PBF (calculated QP:QS 4.7), we elected not
to perform pulmonary vasodilator test. However, af-
ter we placed the ADO to occlude the PDA before we
detached ADO from delivery cable wire, PAP was
decreased to 50 mm Hg. Nevertheless, using an ADO
device to close a very large PDA, as in case 3, may
carry the probability of late embolization due to the
lack of a disk in the pulmonary artery end. In such
a scenario, the Amplatzer muscular ventricular sep-
tal defect occluder has been reported to successfully
close the very large PDA instead [10].
In summary, we have reported three cases with
a large PDA associated with PAH and desaturation,
two of which were also associated with Down syn-
drome. The PAP could be partially improved after
closure of the PDA, and desaturation in two cases
was able to be resolved, while desaturation in the
third case resolved spontaneously.
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Figure 3. Angiography in the descending aorta (DAo) in
patient 3 demonstrated contrast filled into pulmonary
artery (PA) and size of patent ductus arteriosus (PDA)
(A), and angiography after the Amplatzer ductal occlu-
der (ADO) demonstrated proper position of ADO in the
PDA with residual contrast filled via ADO into PA (B).
